Skip to content

Clinical trials

Phase 1/2 Leukemia, B-Cell trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Phase: Phase 1/2 Status: Unknown status Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20172
20181
20193
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd4
Chinese PLA General Hospital2
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China1
Hebei Senlang Biotechnology Inc., Ltd.1
Nanfang Hospital, Southern Medical University1
Shanghai GeneChem Co., Ltd.1
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell11
Lymphoma, B-Cell8
Leukemia4
Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell2
Burkitt Lymphoma1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.